FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreACR Data Science Institute’s AI Central has been updated with three new Transparent-AI products and three new products to the directory.
Three new products were added to our Transparent-AI program, which is designed to increase transparency in imaging AI and help end users have better informed discussions and selection criteria when making decisions about which algorithm might be most appropriate for their local target population.
Perspectum Diagnostics Ltd. joined the Transparent-AI program with their products MRCP+, Hepatica, and LiverMultiScan.
Transparent-AI consists of voluntarily provided data elements solicited from participating imaging AI manufacturers who currently have an FDA-cleared product in the U.S. market. Manufacturers who participate in this program will receive the Transparent-AI badge on their product listing.
Our AI Central directory has also been updated with three new products. This information is pulled directly from FDA 510K documents and updated by ACR staff. With this latest update, we see newly cleared FDA products designed for pediatric x-rays, chest CTs and prostate MR images.
New products include:
EFAI Bonesuite XR Bone Age Pro Assessment System (BAP-XR-100)
Cardiac CT Function Software Application
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreQ&A With Chair of the ACR Commission on Quality and Safety
Q&A with ACR Quality and Safety Chair Ben Wandtke, MD, MS, on AI, imaging quality, performance improvement and the future of radiology care.
Read moreACR 2026 Updates and On-Demand Recordings
ACR 2026 Annual Meeting highlights include election results, resolutions adopted, new practice parameters for imaging AI and access to on-demand recordings.
Read more